Shares in Protolabs (NYSE: PRLB) dropped by nearly 9% today on news of second-quarter medical device sales that would have been worse had it not been for orders that came in response to COVID-19.
The Maple Plain, Minn.-based rapid manufacturing company reported profits of $12.6 million or $0.47 per share, on sales of $106.58 million for the three months ended June 30, 2020, for a bottom-line drop of -22% on a sales shrinkage of -8.86% compared with Q2 2019.
Get the full story on our sister site, Medical Design & Outsourcing.